Research Article

Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab

Table 4

Simulated and measured average total volumes on day 19 ().

Therapy

No therapy 4.68 6.15
Therapy 1 3.10 4.44
Therapy 2 2.13 2.03